83 related articles for article (PubMed ID: 11715472)
21. Apo E gene polymorphism on development of diabetic nephropathy.
Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
[TBL] [Abstract][Full Text] [Related]
22. [Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations].
Lahlali-Kacemi N; Bamou Y; Guedira A; Hassani M; Visvikis S; Siest G; Alami N; Kabbaj O; Lahrichi M
Ann Biol Clin (Paris); 2002; 60(1):73-8. PubMed ID: 11830396
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
24. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
25. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
[TBL] [Abstract][Full Text] [Related]
26. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
27. The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates.
Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
Rheumatology (Oxford); 2003 Mar; 42(3):468-72. PubMed ID: 12626798
[TBL] [Abstract][Full Text] [Related]
28. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.
Moreno JA; Pérez-Jiménez F; Moreno-Luna R; Pérez-Martínez P; Fuentes-Jiménez F; Marín C; Portugal H; Lairon D; López-Miranda J
Br J Nutr; 2009 Jun; 101(12):1745-52. PubMed ID: 19025720
[TBL] [Abstract][Full Text] [Related]
29. Association of methylenetetrahydrofolate (MTHFR) and apolipoprotein E (apo E) genotypes with homocysteine, vitamin and lipid levels in carotid stenosis.
Zuntar I; Antoljak N; Vrkić N; Topić E; Kujundzić N; Demarin V; Vuković V
Coll Antropol; 2006 Dec; 30(4):871-8. PubMed ID: 17243563
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E polymorphism in non-insulin-dependent diabetics of Mumbai, India and its effect on plasma lipids and lipoproteins.
Inamdar PA; Kelkar SM; Devasagayam TP; Bapat MM
Diabetes Res Clin Pract; 2000 Mar; 47(3):217-23. PubMed ID: 10741571
[TBL] [Abstract][Full Text] [Related]
31. Association of serum lipids and apolipoprotein E gene polymorphism with the risk of colorectal adenomas.
Zhongyin Z; Hesheng L; Jun L; Jihong C
Saudi Med J; 2006 Feb; 27(2):161-4. PubMed ID: 16501668
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
Werle E; Fiehn W; Hasslacher C
Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
[TBL] [Abstract][Full Text] [Related]
33. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
Yilmaz H; Agachan B; Karaali ZE; Isbir T
Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
36. [The relationship between apolipoprotein E genotype and hypertriglyceridemia-associated recurrent acute pancreatitis].
WEN T; LIU L; NIE S
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1579-82. PubMed ID: 19094657
[TBL] [Abstract][Full Text] [Related]
37. Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease.
Akanji AO; Suresh CG; Fatania HR; Al-Radwan R; Zubaid M
Metabolism; 2007 Apr; 56(4):484-90. PubMed ID: 17379005
[TBL] [Abstract][Full Text] [Related]
38. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus.
Eto M; Watanabe K; Sato T; Makino I
J Clin Endocrinol Metab; 1989 Dec; 69(6):1207-12. PubMed ID: 2584356
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E gene polymorphism and previous alcohol withdrawal seizures.
Wilhelm J; von Ahsen N; Hillemacher T; Bayerlein K; Frieling H; Kornhuber J; Bleich S
J Psychiatr Res; 2007 Nov; 41(10):871-5. PubMed ID: 16959267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
